Tumor‐necrosis factor can enhance radio‐antibody uptake in human colon carcinoma xenografts by increasing vascular permeability

International Journal of Cancer

Volumn 53, Issue 5, 1993, Pages 829-836

  Folli, Silvio ^a   Épèlegrin, Andr ^a   Chalandon, Yves ^a   Yao, Xiaofei ^a   Buchegger, Franz ^a   Lienard, Danielle ^b   Lejeune, Ferdi ^b   Mach, Jean‐Pierre ^a,c  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; IODINE 125; MONOCLONAL ANTIBODY; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL PERMEABILITY; COLON CARCINOMA; CONTROLLED STUDY; DRUG UPTAKE; HUMAN; HUMAN TISSUE; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; RADIOIODINATION; TUMOR XENOGRAFT;

ANIMAL; ANTIBODIES, MONOCLONAL; CAPILLARY PERMEABILITY; CARCINOEMBRYONIC ANTIGEN; CARCINOMA; COLONIC NEOPLASMS; HUMAN; INJECTIONS, INTRALESIONAL; IODINE RADIOISOTOPES; LIPOPOLYSACCHARIDES; MICE; MICE, NUDE; REGIONAL BLOOD FLOW; SUPPORT, NON-U.S. GOV'T; TRANSPLANTATION, HETEROLOGOUS; TUMOR NECROSIS FACTOR;

EID: 0027467414     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910530521     Document Type: Article

References (31)

1. Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons
2. Clinical value of immunoscintigraphy in colorectal carcinoma patients: a prospective study
3. Influence of animal host and tumor implantation site on radio‐antibody uptake in the GW‐39 human colonic cancer xenograft
4. Use of hematopoietic growth factors to control myelosuppression caused by radioimmunotherapy
5. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies
6. 2 fragments are more efficient and less toxic than intact anti‐CEA antibodies in radioimmunotherapy of large human colon carcinoma grafted in nude mice
7. Establishment of a human carcinoembryonic antigenproducing colonadenocarcinoma cell line
8. Highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes
9. Changes in vascular permeability following thorax irradiation in the rat
10. Immunophotodiagnosis of colon carcinomas in patients injected with fluoresceinated chimeric antibodies against carcinoembryonic antigen
11. The internal milieu of tumors
12. Determinants of tumor blood flow: a review
13. In vivo targets of recombinant human tumour necrosis factor‐alpha: blood flow, oxygen consumption and growth of isotransplanted rat tumours
14. High‐dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma
15. Use of radiolabelled monoclonal anti‐CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy
16. In vivo localisation of radiolabelled antibodies to carcinoembryonic antigen in human colon carcinoma grafted into nude mice
17. Imaging and therapy with monoclonal antibodies in non‐hematopoietic tumors
18. Endotoxin‐mediated necrosis and regression of established tumours in the mouse. A correlative study of quantitative changes in blood flow and ultrastructural morphology
19. Carcinoembryonic antigen production, secretion and kinetics in BALB/c mice and a nude mouse‐human tumor model
20. Interleukin 1 is a radioprotector
21. Tumour necrosis factor. Another chapter in the long history of endotoxin
22. Influence of recombinant tumour necrosis factor alpha on blood flow and antibody localization in human tumour xenografts in nude mice
23. Combination immunotherapy for cancer: synergistic antitumor interactions of interleukin‐2, alfa interferon, and tumor‐infiltrating lymphocytes
24. Effect of tumor necrosis factor on the antitumor efficacy and toxicity of aminopterin‐monoclonal antibody conjugates: parameters for optimization of therapy
25. Longitudinal karyotype and genetic signature analysis of cultured human colon adenocarcinoma cell lines LS180 and LS174T
26. Correlation of vascular permeability and blood flow with monoclonal antibody uptake by human Clousner and renal cell xenografts
27. Use of vasoactive agents to increase tumor perfusion and the antitumor efficacy of drug‐monoclonal antibody conjugates
28. Increased antitumor effect of immunoconjugates and tumor necrosis factor in vivo
29. Effect of tumour necrosis factor and lipid A on functional and structural vascular volume in solid murine tumours
30. Quantitative analysis of antibody localization in human metastatic colon cancer: a phase 1 study of monoclonal antibody a33
31. The measurement of blood perfusion in experimental tumors by uptake of 86Rb